Hims And Hers Surges 40% On Deal To Sell Novo Nordisk Obesity Drugs

CoffeeNFTs · 2026-03-07T22:14:46+00:00

Hims and Hers experienced a 39.8% stock surge following news of a partnership with Novo Nordisk to sell its obesity drugs online, ending previous legal disputes. While both companies faced market challenges, this collaboration may boost their positions.

CoffeeNFTs

2026-03-07 22:14:46

Abstract generation in progress

Hims and Hers (HIMS) surged late Friday on a report that Novo Nordisk (NVO) will sell its obesity drugs via the online pharmacy following a legal fight.

The companies will announce their partnership as soon as Monday, Bloomberg reported late Friday, citing a source. Hims and Novo had a similar deal last year, but the Danish drug giant ended it after the telehealth firm refused to stop selling copycat weight-loss treatments.

				    ↑
					X

This video file cannot be played.(Error Code: 102630)

								How This Uranium Enrichment Technology Aims To Solve The Nuclear Fuel Bottleneck For Big Tech
							

							

								See All Videos
							

						

					
					
						NOW PLAYING
						How This Uranium Enrichment Technology Aims To Solve The Nuclear Fuel Bottleneck For Big Tech

In February, Novo Nordisk sued Hims and Hers for selling a knockoff version of its new Wegovy weight-loss pill. Hims, which also faced heavy FDA pressure, quickly backed down.

However, it still sells injectable treatments with semaglutide, the active ingredient in Novo Nordisk’s Wegovy and Ozempic.

Novo already sells its weight-loss drugs via other telehealth firms such as Ro and WW International’s (WW) Weight Watchers.

Hims And Hers Stock

Hims stock shot up 39.8% to 22 in Friday night trading on the report. Shares are down 51.5% so far in 2026.

Novo stock climbed 2.1% late Friday. Shares are off 24.2% this year.

Eli Lilly (LLY) lost a fraction after hours. LLY stock has declined 7.85% in 2026. The active ingredient in Eli Lilly’s weight-loss drugs is tirzepatide.

WW International stock fell 2.1% in extended Friday action.

Please follow Ed Carson on X at @IBD_ECarson for stock market updates and more.

YOU MIGHT ALSO LIKE:

Catch The Next Big Winning Stock With MarketSurge

Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader

IBD Digital: Unlock IBD’s Premium Stock Lists, Tools And Analysis Today

When It’s Time To Sell Your Favorite Stock

How To Invest: Rules For When To Buy And Sell Stocks In Bull And Bear Markets

Rally Attempt In Play, But Depends On Iran, Oil

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes